Cargando…

Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia

Detalles Bibliográficos
Autores principales:	Tsuchiya, Kazuo, Suzuki, Yuzo, Yoshimura, Katsuhiro, Yasui, Hideki, Karayama, Masato, Hozumi, Hironao, Furuhashi, Kazuki, Enomoto, Noriyuki, Fujisawa, Tomoyuki, Nakamura, Yutaro, Inui, Naoki, Yokomura, Koushi, Suda, Takafumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031333/ https://www.ncbi.nlm.nih.gov/pubmed/32075990 http://dx.doi.org/10.1038/s41598-020-58958-9

Ejemplares similares

Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia
por: Kazuo, Tsuchiya, et al.
Publicado: (2019)

Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis
por: Suzuki, Yuzo, et al.
Publicado: (2018)

Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease
por: Yoshimura, Katsuhiro, et al.
Publicado: (2018)

An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases
por: Tsuchiya, Kazuo, et al.
Publicado: (2018)

Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis
por: Suzuki, Yuzo, et al.
Publicado: (2018)

Pulse oximetric saturation to fraction of inspired oxygen (SpO(2)/FIO(2)) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease
por: Koyauchi, Takafumi, et al.
Publicado: (2020)

Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non–Small Cell Lung Cancer After Nivolumab Therapy
por: Karayama, Masato, et al.
Publicado: (2022)

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Yoshimura, Katsuhiro, et al.
Publicado: (2021)

Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray
por: Karayama, Masato, et al.
Publicado: (2021)

Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease
por: Koda, Keigo, et al.
Publicado: (2021)

Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy
por: Karayama, Masato, et al.
Publicado: (2021)

Pneumothorax in connective tissue disease-associated interstitial lung disease
por: Nishimoto, Koji, et al.
Publicado: (2020)

Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer
por: Tsuchiya, Kazuo, et al.
Publicado: (2019)

Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias
por: Hozumi, Hironao, et al.
Publicado: (2018)

Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis
por: Enomoto, Noriyuki, et al.
Publicado: (2019)

Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial
por: Furuhashi, Kazuki, et al.
Publicado: (2019)

Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy: The Authors' Reply
por: Karayama, Masato, et al.
Publicado: (2019)

Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer
por: Aoshima, Yoichiro, et al.
Publicado: (2019)

Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas
por: Akahori, Daisuke, et al.
Publicado: (2021)

EGFR-Mutated Lung Adenocarcinoma Successfully Treated With Osimertinib After Spontaneous Transformation to SCLC and Adenocarcinoma With Neuroendocrine Differentiation: Case Report
por: Takuma, Sho, et al.
Publicado: (2021)

Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study
por: Koyauchi, Takafumi, et al.
Publicado: (2022)

Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis
por: Enomoto, Noriyuki, et al.
Publicado: (2018)

Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
por: Tanaka, Yuko, et al.
Publicado: (2022)

Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians
por: Koyauchi, Takafumi, et al.
Publicado: (2022)

Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice
por: Akahori, Daisuke, et al.
Publicado: (2022)

Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the BRAF mutation
por: Watanabe, Hirofumi, et al.
Publicado: (2022)

Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report
por: Mochizuka, Yasutaka, et al.
Publicado: (2022)

Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis
por: Suzuki, Takahito, et al.
Publicado: (2022)

Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
por: Aono, Yuya, et al.
Publicado: (2020)

Physiological and morphological differences of airways between COPD and asthma–COPD overlap
por: Karayama, Masato, et al.
Publicado: (2019)

Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease
por: Karayama, Masato, et al.
Publicado: (2019)

Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival
por: Aoshima, Yoichiro, et al.
Publicado: (2021)

Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study
por: Suzuki, Takahito, et al.
Publicado: (2021)

Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
por: Hozumi, Hironao, et al.
Publicado: (2022)

Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report
por: Endo, Yoshinari, et al.
Publicado: (2021)

Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
por: Enomoto, Noriyuki, et al.
Publicado: (2020)

Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis
por: Suzuki, Yuzo, et al.
Publicado: (2021)

Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study
por: Suzuki, Yuzo, et al.
Publicado: (2021)

Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
por: Miyashita, Koichi, et al.
Publicado: (2022)

Respiratory impedance is correlated with morphological changes in the lungs on three-dimensional CT in patients with COPD
por: Karayama, Masato, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_viv48af2vk39q74m27sq5mro5p